News

Atyr Pharma plans to launch a new global clinical trial to test its investigational therapy, efzofitimod, in people with pulmonary sarcoidosis and a restrictive profile, in which the lungs cannot fully expand. The decision follows a type C meeting with the U.S. Food and Drug Administration (FDA) to discuss…

Corticosteroid treatment leads to rapid improvements in kidney function in people with renal sarcoidosis, but later relapses are frequent, requiring additional immunosuppressive therapies, according to a Dutch study. “Our findings support a treatment protocol starting with prednisone [a corticosteroid] … followed by gradual tapering, and the addition of [corticosteroid-sparing]…

A standard heart ultrasound scan, called transthoracic echocardiography (TTE), may help screen for cardiac sarcoidosis when used alongside symptoms and heart rhythm tests, a study found. Adding heart strain imaging or three-dimensional echocardiography did not appear to significantly improve its overall diagnostic value. Although TTE had low sensitivity,…

Black/African American people with sarcoidosis are more likely than non-Hispanic white patients to develop certain eye problems, including inflammation in the front of the eye and nerve damage, a study shows. In contrast, white sarcoidosis patients were found to have a higher risk of inflammation in the back part…

Careful evaluation is required to distinguish among sarcoidosis, silicosis, and silicosarcoidosis, three disorders that can cause similar patterns of lung problems in people exposed to silica, but that progress and respond to treatment differently. A team of scientists in Brazil highlighted the challenges of distinguishing among the three conditions…

Comparing levels of a protein known as ACE, fully, angiotensin-converting enzyme, in urine and blood may help diagnose renal sarcoidosis and assess how severely the kidneys are affected, according to a retrospective analysis of data from a single center in Japan. The findings suggest that measuring ACE levels in…

To mark Sarcoidosis Awareness Month, celebrated each April, the Foundation for Sarcoidosis Research (FSR) has launched a global campaign that was sparked by a kaleidoscope. This year’s awareness initiative — dubbed “See Sarcoidosis” — is designed to spotlight the many presentations of sarcoidosis, which affects each patient differently,…

While sarcoidosis can lead to hospital admission, in-hospital deaths among people with sarcoidosis are most often caused by other conditions rather than the disease itself, according to a real-world national study in Spain. Common causes of death included infections, cardiovascular disease, cancer, and blood clots known as venous thromboembolism…

People with pulmonary sarcoidosis who are older at diagnosis or have more severe lung damage may face a higher risk of death. That’s according to a large study from Spain, in which researchers found that being older than 50 and having a Composite Physiological Index (CPI) score above 35…

People with autoimmune diseases — especially Sjögren’s disease, which affects the glands that produce tears and saliva — may have a significantly higher risk of developing sarcoidosis, according to a study in Japan. The strongest association was seen with Sjögren’s disease, while other autoimmune conditions were also significantly linked…